Invited Presentations and Lectures
  1. "Diagnostic Significance of Aspergillus Isolation from Respiratory Secretions". 11th Internatinal Congress of Chemotherapy and 19th Intersciences Conference on Antimicrobial Agents and Chemotherapy, October 1-5, 1979, Boston, MA.
  2. "Transplant Lymphoproliferative Disorder" - Transplantation Workshop, University of Pittsburgh Continuing Medical Education, January 11, 1984, Pittsburgh, PA.
  3. "Lymphoproliferative Disorders in Transplant Recipients" - Thoracic Surgery Rounds, Stanford University Hospital, February 17, 1984, Stanford, CA.
  4. "Lymphoproliferat6ive Syndrome in Cyclosporin-A Treated Allograft Recipients. International Academy of Pathology" - 73rd Annual Meeting, March 12-16, 1984, San Francisco, CA.
  5. "Immunohistochemistry" - Cytology Workshop, Magee Womens Hospital, May 5, 1984, Pittsburgh, PA.
  6. "Malignant Lymphomas Associated with Immunosuppressive Therapy of Transplant Recipients" - Pennsylvania Association of Clinical Pathologists Annual Meeting, May 2-4, 1985, Pittsburgh, PA.
  7. "Pathophysiology of Atherosclerosis" - University of Pittsburgh Continuing Medical Educations, TIA’s and Stroke Workshop, May 3, 1985, Pittsburgh, PA.
  8. "Lymphoproliferative Lesions in Transplant Patients: The Pittsburgh Experience" - University of Nebraska, May 27, 1986, Omaha, NE
  9. "Lymphoproliferative Disorders in the Transplant Patient" - The Pittsburgh Experience" - University of Pittsburgh Continuing Medical Education. Transplantation Pathology and Host Responses, April 3-5, 1987, Pittsburgh, PA.
  10. "Toxicology of the Experimental Immunosuppressant FR900506" - Roundtable Discussion, European Society for Organ Transplantation, June 2-6, 1987, Goteborg, Sweden.
  11. "Clonal Analysis of Post-transplant Lymphoproliferative Disorders" - International Organ Transplant Forum Honoring Thomas E. Starzl, September 8-11, 1987, Pittsburgh, PA.
  12. "Toxicology of the Experimental Immunosuppressive FK506 (Fujisawa): Results of Animal Studies" - Food and Drug Administration, March 18, 1988, Rockville, MD.
  13. "Post-transplant Lymphoproliferative Disorders in Renal Allografts" - Poster Presentation. US and Canadian Academy of Pathology, March 5-10, 1989, San Francisco, CA.
  14. "Post-transplant Lymphoproliferative Disorders" - Gastrointestinal Pathology Society, United States and Canadian Branch of the International Academy of Pathology Annual Meeting, March 5, 1989, San Francisco, CA.
  15. "Opportunistic Cancers in Immunosuppressed Organ Transplant Recipients" - Pittsburgh Pathology Society, January 17, 1990, Pittsburgh, PA.
  16. "Lymphoproliferative Disorders Arising Under Immunosuppression with FK506: Early Observations in a Large Transplant Population" - XIII International Congress of the Transplantation Society, August 19-24, 1990, San Francisco, CA.
  17. "Immunosuppression and Lymphoproliferative Disorders" - University of Cincinnati Roundtable Discussion, June 7, 1991.
  18. "The Pathology of Liver Transplantation" - University of Rochester Medical Center, Pathology Grand Rounds, January, 1992.
  19. "Pathology at a Transplant Center" - December 18, 1992, Pittsburgh, PA.
  20. "NIH Meeting (AIDS Lymphomas)", Rockville, MD, 1992.
  21. "Lymphoproliferative Disease in Organ Transplant Recipients" - University of Pennsylvania Medical Center, February, 1993.
  22. "EBV Related Post-transplant Lymphoproliferative Disease - Pathogenesis and Pathology" - Pediatric Heart and Lung Transplant Study Group, satellite meeting of 13th Annual Meeting of the International Society for Heart and Lung Transplantation, April 2, 1993, Boca Raton, FL.
  23. "Post-transplant Lymphoproliferative Disorders: Current Aspects" - Irving Slotnick Memorial Lecture, Cedars-Sinai Hospital, May 15, 1993, Los Angeles, CA.
  24. "Some Interesting Cases on the Transplant Bench (Slide Presentation)" - Cedars-Sinai Hospital, May 15, 1993, Los Angeles, CA.
  25. "Pathologic Studies of Epstein-Barr Virus-Associated Post-transplant Lymphoproliferative Disorders" - Institute of Virology, Slovak Academy of Sciences, April 6-11, 1994, Bratislava, Slovakia.
  26. "Lymphoproliferative Disorders After Renal Transplantation" - Royal Society of Medicine, June 21, 1994, London, England.
  27. "Carr, BI and Nalesnik, MA: "Expression of TGF-alpha in hepatocellular carcinomas" - XVI International Cancer Congress, New Delhi, India, October 30-November 5, 1994.
  28. Madariaga JR, Iwatsuki S, Nalesnik M, Tsamandas AC, Irish W, Sahir M, Karavias D, Fung JJ, Starzl TE: "Liver resection for primary sarcomas: An analysis of 17 cases". American Association for the Study of Liver DIsease, Chicago Ill. Nov 3-7, 1995.
  29. Madariaga JR, Iwatsuki S, Nalesnik M, Tsamandas AC, Irish W, Sahir M, Karavias D, Fung JJ, Starzl TE: "Liver resection for metastatic sarcomas: A review of 20 cases". American Association for the Study of Liver DIsease, Chicago Ill. Nov 3-7, 1995.
  30. Randhawa P, Demetris AJ, Nalesnik MA. "Differentiation of renal Epstein-Barr virus (EBV) associated post-transplant lymphoproliferative disease (PTLD) from severe acute rejection (AR), using the Banff Schema." US & Canadian Academy of Pathology Meeting, Washington D.C., March 1996.
  31. "Posttransplant Lymphomas". Belgian Transplantation Society Annual Meeting, Brussels, Belgium, Feb. 27-March 2, 1997.
  32. "Minisymposium on Posttransplant Lymphoproliferative Disorders (Chairman)" Fourth Banff Conference on Allograft Pathology, Banff, Alberta, Canada, March 7-12, 1997.
  33. " Evening Slide Conference (Organizer and Moderator)", Fourth Banff Conference on Allograft Pathology, Banff, Alberta, Canada, March 7-12, 1997.
  34. "Pathology of PTLD" (Working Group Chairman) - International Consensus Meeting on EBV-Induced Posttransplant Lymphoproliferative Disorders (PTLD). Chicago IL May 10, 1997.
  35. "LAK cell therapy of posttransplant lymphoproliferative disorders" (Poster presentation). American Society of Transplant Physicians, 16th Annual Meeting, Chicago IL, May 10-14, 1997.
  36. Torbenson M, Wang J, Nichols L, Jain A, Fung J, Nalesnik MA: "Occult malignancies present at the time of transplantation." United States and Canadian Academy of Pathology Annual Meeting, Boston MA Feb. 28-Mar 6, 1998.
  37. Minervini MI, Swerdlow SH, Zeevi A, Randhawa PS, Demetris AJ, Nalesnik MA." Polymorphous posttransplant disorders (PTLD) are B cell tumors with numerous infiltrating T cells". United States and Canadian Academy of Pathology Annual Meeting, Boston MA Feb. 28-Mar 6, 1998.
  38. "Pathology of EBV-related lymphoproliferative disorders". Workshop on EBV-related lymphoproliferative disorders in transplant recipients- new advances. Almo Collegio Borromeo Sala d'egli Affreschi, Pavia, Italy April 2, 1998.
  39. "Clinicopathologic Features of Posttransplant Lymphoproliferative Disorders" (Lecture and Glass Slide Conference), Visiting Professor, University of Massachusetts, April 15, 1998.
  40. Practical Pathologic Aspects of Posttransplant Lymphoproliferative Disorders. (Lecture and Glass Slide Presentation). Children's Cancer Group Spring Meeting, Houston TX April 24, 1998.
  41. Pathology and Pathogenesis of Posttransplant Lymphoproliferative Disorders. Symposium on Posttransplant Infections- Prevention and Control. Oklahoma Transplantation Institute, Oklahoma City, OK, May 8, 1998.
  42. "Update on Posttransplant Lymphoproliferative Disorders". (Luncheon Workshop). American Society of Transplant Physicians 17th Annual Meeting, Chicago, IL May 10, 1998.
  43. Minervini MI, Pavlick M, Zeevi A, Rao A, Fung JJ, Nalesnik MA. "Cytotoxicity of LAK cells and EBV-specific T cells against lymphoblastoid EBV-positive B cells. A model for cellular therapy of PTLD". (Oral presentation) American Society of Transplant Physicians 17th Annual Meeting, Chicago, IL May 12, 1998.
  44. Minervini MI, Zeevi A, Whiteside TL, Moga CN, Rao A, Fung JJ, Nalesnik MA "Tumor infiltrating T Lymphocytes in Posttransplant Lymphoproliferative Disorders (PTLD)" (oral presentation). XVII World Congress of The Transplantation Society, Montreal Canada July 12-17, 1998.
  45. "Molecular Pathology of Posttransplant Lymphoproliferative Disease". Experimental Pathology and Molecular Pathology Sections of the Canadian Association of Pathologists, Royal College of Physicians and Surgeons Annual Meeting, Toronto, Canada, Sept. 25, 1998.
  46. Posttransplant Lymphoproliferative Disease and other Posttransplant Malignancies. Inova Transplant Center, Inova Fairfax Hospital, Falls Church VA. October 17, 1998.
  47. Co-Chairman, "Diagnosis of PTLD" Workshop, American Society of Transplant Physicians ad hoc Task Force on EBV-PTLD" Bethesda, MD November 11, 1998
  48. "Diagnostic Aspects of Posttransplant Lymphoproliferative Disorders,"ASTP Workshop on Posttransplant Lymphoproliferative Disease, Bethesda MD, November 12, 1998.
  49. Shapiro R, Nalesnik M, McCauley J. Fedorek S, Jordan ML, Scantlebury VP, Vivas C, Ellis D, Lombardozzi-Lane S, Randhawa P, Johnston J, Hakala TR, Simmons RL, Fung JJ, Starzl TE: Post-Transplant lymphoproliferative disorders (PTLD) in adult and pediatric renal transplant patients receiving Tacrolimus-based immunosuppression (Poster presentation) American Society of Transplant Physicians, May 1999
  50. EBV Sequelae in Transplantation: Post Transplant Lymphoproliferative Disorder. American Society for Histocompatibility and Immunogenetics. 25th meeting. New Orleans LA Oct 20-24, 1999.
  51. Nalesnik MA, Torbenson T, Falini B, Finkelstein S, Baksh F, Swerdlow SH: Germinal Center and Post-Germinal Center Phenotypes in Posttransplant Lymphoproliferative Disorders (PTLD) (poster presentation). United States and Canadian Academy of Pathology Annual Meeting, New Orleans LA, March 25-31 2000
  52. Jain A, Reyes J, Mazariegos G, Kashyap R, Jaffe R, Fung J, Nalesnik M. Comparison of Post Transplant Lymphoproliferative Disorders (PTLD) in Children under Cyclosporine and Tacrolimus, 766 Consecutive Recipients: 15 Years Experience. (poster presentation). First IPTA Conference on Pediatric Transplantation, Venice Italy August 23-25, 2000.
  53. "Lymphoproliferative Syndromes in Organ Transplantation." First Annual Meeting of the Andalusian Society of Transplantation, Marbella, Spain, November 22-25, 2000.
  54. "Clinicopathologic Characteristics of Posttransplant Lymphoproliferative Disorders". Third Symposium on Immunodeficiencies and Malignancies. Charite-Campus Virchows Clinic, Berlin, Germany February 16-17, 2001.
  55. Torbenson M, Kashyap R, Randhawa P, Jain A, Nalesnik MA. Renal carcinomas in the setting of post-transplant immunosuppression. US & Canadian Academy of Pathology Meeting, Atlanta, GA, March 6, 2001.
  56. Cacciarelli TV, Subotin M, Fung JJ, Nalesnik MA: Epstein-Barr Virus Negative Post-transplant Lymphoproliferative Disorder and Liver Transplantation. Annual Joint Meeting of the International Liver Transplantation Society, the European Liver Transplant Association and the Liver Intensive Care Group of Europe, Berlin, Germany, July 11-13 , 2001.
  57. "What is and What is Not PTLD?" American Society of Transplant Surgeons Third Annual Winter Symposium, Miami FL, January 24-26, 2003.
  58. Funch DP, Ko HH, Travasso J, Mechlowicz J, Nalesnik MA, Kew C III, Walker AM: Association between Mycophenolate Mofetil (MMF) and Development of Post-Transplant Lymphoproliferative Disorder in Renal Transplant Patients in the U.S. American Transplantation Congress, Washington, D.C., May 30 - June 4, 2003.